featured-image

Could Ozempic be the answer to a longer life? It’s the question many scientists are asking about the controversial drug, a glucagon-like peptide-1 receptor agonist (GLP-1), as some research suggests it could help humans age with less chronic diseases. The same goes for glucose-dependent insulinotropic peptide receptor agonists (GIP) such as Zepbound and Mounjaro, leaving some experts to start seeing them as potential longevity pills and considering how in the future they can be prescribed safely to more people, especially as rates of obesity continue to rise. “The singular most effective and consistent way of extending lifespan in animals is caloric restriction,” says Dr.

Douglas Vaughan, a professor of medicine at Northwestern University and director of the Potocsnak Longevity Institute. “That’s been demonstrated to work on everything from worms to flies to mice to monkeys. If you can find a way to get people to chronically reduce their caloric intake, it sort of makes sense that it might have an effect on aging.



It’s probably not as simple as that and there could be unexpected effects of these drugs that might negate or prevent the anti aging effect, but it’s a great hypothesis and it needs to be tested rigorously.” Originally, semaglutide and similar drugs were primarily developed to manage type 2 diabetes . They work by activating GLP-1 receptors and increasing insulin levels in the body and thereby decreasing glucose levels.

They can help with appetite su.

Back to Health Page